Product Introduction
Granexa 1 Mg Suspension contains Repaglinide, an oral antidiabetic agent used to manage Type 2 Diabetes Mellitus. This suspension formulation helps control blood sugar spikes after meals by stimulating the pancreas to release insulin quickly. It is ideal for patients who have difficulty swallowing tablets or require flexible dosing.
Uses of Granexa Suspension
-
Treatment of Type 2 Diabetes Mellitus
-
Control of postprandial hyperglycemia (high blood sugar after meals)
-
Alternative to tablet form for better compliance
Benefits of Granexa Suspension
-
Rapid onset to manage blood sugar spikes after eating
-
Easy to administer for patients with swallowing difficulties
-
Improves overall glycemic control
-
Short duration reduces risk of prolonged hypoglycemia
Composition:
-
Repaglinide – 1 mg per 5 ml
Side Effects
-
Hypoglycemia (low blood sugar)
-
Nausea or vomiting
-
Headache or dizziness
-
Weight gain (less common)
-
Rare allergic reactions
Safety Advice
-
Take as directed, usually before meals
-
Monitor blood sugar regularly
-
Avoid skipping meals to prevent hypoglycemia
-
Inform doctor if pregnant or breastfeeding
-
Use caution in patients with liver or kidney impairment
-
Store in a cool, dry place away from direct sunlight
